These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 18689579)
1. Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports. Fernández AB; Karas RH; Alsheikh-Ali AA; Thompson PD Chest; 2008 Oct; 134(4):824-830. PubMed ID: 18689579 [TBL] [Abstract][Full Text] [Related]
2. Statins and the risk of interstitial lung disease: a cohort study. Saad N; Camus P; Suissa S; Ernst P Thorax; 2013 Apr; 68(4):361-4. PubMed ID: 23299962 [TBL] [Abstract][Full Text] [Related]
3. Statin-associated ocular disorders: the FDA and ADRAC data. Mizranita V; Pratisto EH Int J Clin Pharm; 2015 Oct; 37(5):844-50. PubMed ID: 25939673 [TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Chang JT; Staffa JA; Parks M; Green L Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925 [TBL] [Abstract][Full Text] [Related]
5. Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System. Wu B; Shen P; Yin X; Yu L; Wu F; Chen C; Li J; Xu T Br J Clin Pharmacol; 2023 Feb; 89(2):440-448. PubMed ID: 35349180 [TBL] [Abstract][Full Text] [Related]
6. Assessment of statin-induced interstitial pneumonia in patients treated for hyperlipidemia using a health insurance claims database in Japan. Momo K; Takagi A; Miyaji A; Koinuma M Pulm Pharmacol Ther; 2018 Jun; 50():88-92. PubMed ID: 29627482 [TBL] [Abstract][Full Text] [Related]
7. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system. Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724 [TBL] [Abstract][Full Text] [Related]
8. Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature. Roberto G; Biagi C; Montanaro N; Koci A; Moretti U; Motola D Eur J Clin Pharmacol; 2012 Jun; 68(6):1007-11. PubMed ID: 22286160 [TBL] [Abstract][Full Text] [Related]
9. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use. Fraunfelder FW; Richards AB Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555 [TBL] [Abstract][Full Text] [Related]
10. Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS. Fujimoto M; Hosomi K; Takada M Int J Clin Pharmacol Ther; 2014 Apr; 52(4):259-66. PubMed ID: 24472404 [TBL] [Abstract][Full Text] [Related]
11. Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database. Fujimoto M; Higuchi T; Hosomi K; Takada M Int J Med Sci; 2015; 12(3):223-33. PubMed ID: 25678839 [TBL] [Abstract][Full Text] [Related]
12. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase. Edwards IR; Star K; Kiuru A Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877 [TBL] [Abstract][Full Text] [Related]
13. Association of statin use with sleep disturbances: data mining of a spontaneous reporting database and a prescription database. Takada M; Fujimoto M; Yamazaki K; Takamoto M; Hosomi K Drug Saf; 2014 Jun; 37(6):421-31. PubMed ID: 24743876 [TBL] [Abstract][Full Text] [Related]
15. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis. McAdams M; Staffa J; Dal Pan G Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291 [TBL] [Abstract][Full Text] [Related]
16. Effect of statins on blood pressure: Analysis on adverse events released by FDA. You T; Liu XG; Hou XD; Wang XK; Xie HH; Ding F; Yi K; Zhang P; Xie XD Clin Exp Hypertens; 2017; 39(4):325-329. PubMed ID: 28513233 [TBL] [Abstract][Full Text] [Related]
17. Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System. Golomb BA; Verden A; Messner AK; Koslik HJ; Hoffman KB Drug Saf; 2018 Apr; 41(4):403-413. PubMed ID: 29427042 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects. Nawa H; Hamano H; Niimura T; Miyata K; Yagi K; Goda M; Zamami Y; Ishizawa K Clin Transl Sci; 2022 Dec; 15(12):2982-2988. PubMed ID: 36128688 [TBL] [Abstract][Full Text] [Related]
19. Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilance. Pinheiro L; Blake K; Januskiene J; Yue QY; Arlett P Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):705-12. PubMed ID: 27004571 [TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors-associated interstitial lung disease used in non-small cell lung cancer: a pharmacovigilance analysis based on the FDA adverse event reporting system database. Zhang J; Qiu T; Zhou Y; Wu S; Chen E Expert Opin Drug Saf; 2023; 22(9):849-856. PubMed ID: 37026465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]